Clinical Trial Update: ICATA Asthma Mechanistic Study

View source ↗

Summary

The ICATA asthma mechanistic clinical trial sponsored by the National Institute of Allergy and Infectious Diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma | Status: COMPLETED